Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Broad Institute at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Broad Institute brings 4 presentations to Discovery on Target 2026 in Boston. Its program spans genetically validated targets and new modalities, from the CARD9 signalosome to small molecules that induce protein degradation. It also covers protein editing with proximity-inducing molecules and FGFR2 biparatopic antibodies for cholangiocarcinoma.

OrganizationDiscovery on Target 2026 Attendance
Broad Institute
Cambridge, MA
Academic & healthcare
Biomedical and genomic research institute in Cambridge, Massachusetts, founded by MIT and Harvard.
Talk
Tue Sep 29
9:35am–10:05am
From Genetic Validation to Lead Generation: Targeting the CARD9 Signalosome
Emerging Drug Targets
Talk
Tue Sep 29
10:35am–11:05am
Diverse Mechanisms of Small Molecule-Induced Protein Degradation
Novel Drug Modalities
Talk
Wed Sep 30
3:05pm–3:35pm
Protein Editing Using Proximity-inducing Molecules
Novel Drug Modalities
Talk
Thu Oct 1
3:35pm–3:50pm
Novel FGFR2 Biparatopic Antibodies for the Treatment of Cholangiocarcinoma
Novel Drug Modalities

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Broad Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction